377 related articles for article (PubMed ID: 21212282)
1. Kaposi sarcoma-associated herpesvirus degrades cellular Toll-interleukin-1 receptor domain-containing adaptor-inducing beta-interferon (TRIF).
Ahmad H; Gubbels R; Ehlers E; Meyer F; Waterbury T; Lin R; Zhang L
J Biol Chem; 2011 Mar; 286(10):7865-7872. PubMed ID: 21212282
[TBL] [Abstract][Full Text] [Related]
2. TLR-TRIF pathway enhances the expression of KSHV replication and transcription activator.
Meyer F; Ehlers E; Steadman A; Waterbury T; Cao M; Zhang L
J Biol Chem; 2013 Jul; 288(28):20435-42. PubMed ID: 23723066
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's Sarcoma-Associated Herpesvirus Reduces Cellular Myeloid Differentiation Primary-Response Gene 88 (MyD88) Expression via Modulation of Its RNA.
Lingel A; Ehlers E; Wang Q; Cao M; Wood C; Lin R; Zhang L
J Virol; 2016 Jan; 90(1):180-8. PubMed ID: 26468534
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus-encoded replication and transcription activator impairs innate immunity via ubiquitin-mediated degradation of myeloid differentiation factor 88.
Zhao Q; Liang D; Sun R; Jia B; Xia T; Xiao H; Lan K
J Virol; 2015 Jan; 89(1):415-27. PubMed ID: 25320320
[TBL] [Abstract][Full Text] [Related]
5. KSHV RTA Induces Degradation of the Host Transcription Repressor ID2 To Promote the Viral Lytic Cycle.
Combs LR; Spires LM; Alonso JD; Papp B; Toth Z
J Virol; 2022 Jun; 96(12):e0010122. PubMed ID: 35604218
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation.
Izumiya Y; Kobayashi K; Kim KY; Pochampalli M; Izumiya C; Shevchenko B; Wang DH; Huerta SB; Martinez A; Campbell M; Kung HJ
PLoS Pathog; 2013; 9(8):e1003506. PubMed ID: 23990779
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication.
Yang Z; Yan Z; Wood C
J Virol; 2008 Apr; 82(7):3590-603. PubMed ID: 18216089
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus processivity factor (PF-8) recruits cellular E3 ubiquitin ligase CHFR to promote PARP1 degradation and lytic replication.
Chung WC; Lee S; Kim Y; Seo JB; Song MJ
PLoS Pathog; 2021 Jan; 17(1):e1009261. PubMed ID: 33508027
[TBL] [Abstract][Full Text] [Related]
9. NCOA2 promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus by enhancing the expression of the master switch protein RTA.
Wei X; Bai L; Dong L; Liu H; Xing P; Zhou Z; Wu S; Lan K
PLoS Pathog; 2019 Nov; 15(11):e1008160. PubMed ID: 31751430
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
11. Major Histocompatibility Complex Class II HLA-DRα Is Downregulated by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Lytic Transactivator RTA and MARCH8.
Sun Z; Jha HC; Pei YG; Robertson ES
J Virol; 2016 Sep; 90(18):8047-58. PubMed ID: 27356905
[TBL] [Abstract][Full Text] [Related]
12. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM
Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750
[TBL] [Abstract][Full Text] [Related]
13. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG
J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway.
Gould F; Harrison SM; Hewitt EW; Whitehouse A
J Virol; 2009 Jul; 83(13):6727-38. PubMed ID: 19369342
[TBL] [Abstract][Full Text] [Related]
15. Modulation of human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus replication and transcription activator transactivation by interferon regulatory factor 7.
Wang J; Zhang J; Zhang L; Harrington W; West JT; Wood C
J Virol; 2005 Feb; 79(4):2420-31. PubMed ID: 15681443
[TBL] [Abstract][Full Text] [Related]
16. KSHV RTA utilizes the host E3 ubiquitin ligase complex RNF20/40 to drive lytic reactivation.
Spires LM; Wind E; Papp B; Toth Z
J Virol; 2023 Nov; 97(11):e0138923. PubMed ID: 37888983
[TBL] [Abstract][Full Text] [Related]
17. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
[TBL] [Abstract][Full Text] [Related]
18. Lysine residues of interferon regulatory factor 7 affect the replication and transcription activator-mediated lytic replication of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.
Zhang T; Wang Y; Zhang L; Liu B; Xie J; Wood C; Wang J
J Gen Virol; 2011 Jan; 92(Pt 1):181-7. PubMed ID: 20844090
[TBL] [Abstract][Full Text] [Related]
19. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD.
Qu L; Feng Z; Yamane D; Liang Y; Lanford RE; Li K; Lemon SM
PLoS Pathog; 2011 Sep; 7(9):e1002169. PubMed ID: 21931545
[TBL] [Abstract][Full Text] [Related]
20. The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.
Yang Z; Wood C
J Virol; 2007 Jun; 81(12):6294-306. PubMed ID: 17409159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
